New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 27, 2014
07:05 EDTAMEDAmedisys sees Q2 adjusted EPS from cont. operations 15c-20c
May not compare to EPS consensus 0c. Sees Q2 revenue $300M-$305M, consensus $296.64M. The company said, "These results are subject to completion of the quarter, as well as the company's quarterly financial and accounting procedures, and the company's actual results could vary from these estimates. The company previously announced plans to close or consolidate care centers and right-size general and administrative expenses. As a result of these initiatives, the company has been able to improve gross margins and reduce direct and general and administrative costs, favorably impacting second quarter results. While these results represent a significant improvement from Q1, we remain cautious on our full-year outlook due to the seasonality of the business and the early-stage nature of some of the performance initiatives undertaken thus far in 2014."
News For AMED From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 16, 2014
08:35 EDTAMEDAmedisys names Paul Kusserow as CEO
Amedisys announced that its board has named Paul Kusserow as president and CEO and a member of the board. Kusserow will assume the role on December 16, from president and Interim CEO, Ronald LaBorde, who will remain a member of the senior management team in the role of vice chairman. LaBorde will also continue to serve as a member of the board. Kusserow was most recently vice chairman of Alignment Healthcare.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use